GB2420076A - Skincare composition - Google Patents
Skincare composition Download PDFInfo
- Publication number
- GB2420076A GB2420076A GB0520896A GB0520896A GB2420076A GB 2420076 A GB2420076 A GB 2420076A GB 0520896 A GB0520896 A GB 0520896A GB 0520896 A GB0520896 A GB 0520896A GB 2420076 A GB2420076 A GB 2420076A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- weight
- concentration
- surfactant
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 85
- 239000012071 phase Substances 0.000 claims abstract description 53
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 43
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims abstract description 43
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 43
- 229940008099 dimethicone Drugs 0.000 claims abstract description 39
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 36
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical group CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000004094 surface-active agent Substances 0.000 claims abstract description 33
- 229920001213 Polysorbate 20 Polymers 0.000 claims abstract description 30
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims abstract description 30
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims abstract description 30
- 229940068977 polysorbate 20 Drugs 0.000 claims abstract description 30
- 229920001971 elastomer Polymers 0.000 claims abstract description 23
- 239000000806 elastomer Substances 0.000 claims abstract description 23
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000008346 aqueous phase Substances 0.000 claims abstract description 12
- 239000003921 oil Substances 0.000 claims description 37
- 239000004615 ingredient Substances 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 19
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 5
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 3
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 2
- 229920002554 vinyl polymer Polymers 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000004927 clay Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000003945 anionic surfactant Substances 0.000 abstract description 4
- 238000009499 grossing Methods 0.000 abstract description 3
- 230000000699 topical effect Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 60
- 238000003756 stirring Methods 0.000 description 42
- 210000003491 skin Anatomy 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 235000011187 glycerol Nutrition 0.000 description 30
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 29
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 29
- 239000010445 mica Substances 0.000 description 29
- 229910052618 mica group Inorganic materials 0.000 description 29
- 235000019198 oils Nutrition 0.000 description 29
- 229920002379 silicone rubber Polymers 0.000 description 15
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 206010040844 Skin exfoliation Diseases 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 7
- 239000008187 granular material Substances 0.000 description 7
- 238000004299 exfoliation Methods 0.000 description 6
- 230000001815 facial effect Effects 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 3
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 2
- MNRBGFKCVTVNBA-UHFFFAOYSA-N 2-Hydroxyundecanoate Chemical compound CCCCCCCCCC(O)C(O)=O MNRBGFKCVTVNBA-UHFFFAOYSA-N 0.000 description 2
- GHPVDCPCKSNJDR-UHFFFAOYSA-N 2-hydroxydecanoic acid Chemical compound CCCCCCCCC(O)C(O)=O GHPVDCPCKSNJDR-UHFFFAOYSA-N 0.000 description 2
- YDZIJQXINJLRLL-UHFFFAOYSA-N 2-hydroxydodecanoic acid Chemical compound CCCCCCCCCCC(O)C(O)=O YDZIJQXINJLRLL-UHFFFAOYSA-N 0.000 description 2
- JYZJYKOZGGEXSX-UHFFFAOYSA-N 2-hydroxymyristic acid Chemical compound CCCCCCCCCCCCC(O)C(O)=O JYZJYKOZGGEXSX-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- NPOAOTPXWNWTSH-UHFFFAOYSA-N 3-hydroxy-3-methylglutaric acid Chemical compound OC(=O)CC(O)(C)CC(O)=O NPOAOTPXWNWTSH-UHFFFAOYSA-N 0.000 description 2
- KEGHVPSZIWXTPY-UHFFFAOYSA-N 3-hydroxy-3-methylpentanoic acid Chemical compound CCC(C)(O)CC(O)=O KEGHVPSZIWXTPY-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 2
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- QXKAIJAYHKCRRA-UHFFFAOYSA-N D-lyxonic acid Natural products OCC(O)C(O)C(O)C(O)=O QXKAIJAYHKCRRA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 244000018633 Prunus armeniaca Species 0.000 description 2
- 235000009827 Prunus armeniaca Nutrition 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 229940113911 c12-13 pareth-3 Drugs 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 239000008262 pumice Substances 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229940098780 tribehenin Drugs 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- NWCHELUCVWSRRS-SECBINFHSA-N (2r)-2-hydroxy-2-phenylpropanoic acid Chemical compound OC(=O)[C@@](O)(C)C1=CC=CC=C1 NWCHELUCVWSRRS-SECBINFHSA-N 0.000 description 1
- RGHNJXZEOKUKBD-TXICZTDVSA-N (2r,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-TXICZTDVSA-N 0.000 description 1
- WQKLGQXWHKQTPO-UXRZSMILSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WQKLGQXWHKQTPO-UXRZSMILSA-N 0.000 description 1
- RGHNJXZEOKUKBD-STGXQOJASA-N (2s,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C(O)=O RGHNJXZEOKUKBD-STGXQOJASA-N 0.000 description 1
- VIVCRCODGMFTFY-JPRIQSOUSA-N (4s,5s)-3,4-dihydroxy-5-[(1r,2r)-1,2,3-trihydroxypropyl]oxolan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@@H]1OC(=O)C(O)[C@@H]1O VIVCRCODGMFTFY-JPRIQSOUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- FKMHSNTVILORFA-UHFFFAOYSA-N 2-[2-(2-dodecoxyethoxy)ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCO FKMHSNTVILORFA-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- BTJFTHOOADNOOS-UHFFFAOYSA-N 2-hydroxynonanoic acid Chemical compound CCCCCCCC(O)C(O)=O BTJFTHOOADNOOS-UHFFFAOYSA-N 0.000 description 1
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- UOFXSBOAZYCBAV-UHFFFAOYSA-N 8-methylnonyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCCCC(C)C UOFXSBOAZYCBAV-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-AIHAYLRMSA-N D-altronic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O RGHNJXZEOKUKBD-AIHAYLRMSA-N 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- JPIJQSOTBSSVTP-PWNYCUMCSA-N D-erythronic acid Chemical compound OC[C@@H](O)[C@@H](O)C(O)=O JPIJQSOTBSSVTP-PWNYCUMCSA-N 0.000 description 1
- RGHNJXZEOKUKBD-MGCNEYSASA-N D-galactonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-MGCNEYSASA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 description 1
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- QXKAIJAYHKCRRA-UZBSEBFBSA-N D-lyxonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-UZBSEBFBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- QXKAIJAYHKCRRA-BXXZVTAOSA-N D-ribonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(O)=O QXKAIJAYHKCRRA-BXXZVTAOSA-N 0.000 description 1
- JPIJQSOTBSSVTP-GBXIJSLDSA-N D-threonic acid Chemical compound OC[C@@H](O)[C@H](O)C(O)=O JPIJQSOTBSSVTP-GBXIJSLDSA-N 0.000 description 1
- QXKAIJAYHKCRRA-FLRLBIABSA-N D-xylonic acid Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C(O)=O QXKAIJAYHKCRRA-FLRLBIABSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-QTBDOELSSA-N L-gulonic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O RGHNJXZEOKUKBD-QTBDOELSSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SKNVOMKLSA-N L-idonic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SKNVOMKLSA-N 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 241000218213 Morus <angiosperm> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 235000010677 Origanum vulgare Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000218196 Persea Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000141804 Theobroma grandiflorum Species 0.000 description 1
- 235000002424 Theobroma grandiflorum Nutrition 0.000 description 1
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- 230000037386 abnormal desquamation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940075506 behentrimonium chloride Drugs 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical compound C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 description 1
- 229940087675 benzilic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 229960002788 cetrimonium chloride Drugs 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- WTXGYGWMPUGBAL-MGCNEYSASA-N galactonolactone Chemical compound O[C@@H]1COC(=O)[C@H](O)[C@@H](O)[C@H]1O WTXGYGWMPUGBAL-MGCNEYSASA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229950002441 glucurolactone Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940040923 isodecyl laurate Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940033357 isopropyl laurate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 229940057905 laureth-3 Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000037211 monthly cycles Effects 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 229940093446 oleth-5 Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940116393 ppg-20 methyl glucose ether Drugs 0.000 description 1
- VZKNAUXVJXVEAG-UHFFFAOYSA-N propan-2-yl hexadecanoate;propan-2-yl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C.CCCCCCCCCCCCCCCC(=O)OC(C)C VZKNAUXVJXVEAG-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229940096501 sodium cocoamphoacetate Drugs 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- MAYCICSNZYXLHB-UHFFFAOYSA-N tricaproin Chemical compound CCCCCC(=O)OCC(OC(=O)CCCCC)COC(=O)CCCCC MAYCICSNZYXLHB-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/03—Liquid compositions with two or more distinct layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4993—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/91—Graft copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
There is disclosed a composition for topical application to the skin. The composition comprises: a) from 30% to 75% by weight of oil phase; b) from 1% to 20% by weight of surfactant; c) from 0.01 to 20% by weight of an elastomer; and d) from 2% to 40% by weight of aqueous phase. The composition provides a cleansing and smoothing effect on the skin. In a preferred embodiment, the oil phase is caprylic/capric triglyceride, the anionic surfactant is polysorbate 20, and the elastomer is dimethicone crosspolymer.
Description
I
Title - Skincare Composition The present invention relates to a skincare composition and in particular to a composition for cleansing the skin.
The stratum corneum, the outermost layer of the skin, provides a moisturised and flexible barrier and consists of numerous layers of tough plate-like cells set in a highly organised lipid environment. These cells are constantly renewed by the epidermis, and under normal conditions they flake away at the skin's surface. This process of sloughing off cells on the skin's surface is called desquamation, and it is by this process that the skin naturally exfoliates. On average, skin cell renewal (from cell division at the base of the epidermis to loss at the stratum corneum surface) occurs on a monthly cycle and approximately one cell layer per day is lost. The process is important in maintaining a flexible, moisturised and fresh-looking appearance to the skin.
The cells on the outermost surface are less hydrated than those deeper in the stratum corneum. Thus slower renewal of cells and/or their defective exfoliation can leave the surface drier, duller and less flexible. Such deficiencies can be brought about by two notable environmental factors sun exposure and exposure to aggressive detergents. It is also important to note that abnormal desquamation can also affect the hair follicles, where build up of dead cells contributes to follicular blockage and thus comedone formation, and potentially acne.
The use of an exfoliant can enhance the natural process of desquamation, by removal of the dead cells on the top layer of the skin to reveal newer cells underneath. The use of an exfoliant makes the skin look and feel much smoother. Immediately after exfoliation, many consumers notice an initial "glow'. Facial exfoliators refine and brighten the complexion, the skin feels hydrated and nourished, and pores may be left feeling clean and tight.
Exfoliators may help diminish obvious pores by keeping the pores free of unwanted material, which can result in the perception of reduced pore size.
Exfoliants can be used all over the body. Physical exfoliation treatments are normally used on legs, arms and trunk of the body. Examples of such treatments include loofahs, abrasive sponges, pads, brushes and "scrubs".
Facial skin is fine and more delicate than the skin on the rest of the body, and so consumers are advised to exfoliate the face with compositions containing finer scrub ingredients and/or other non-granular exfoliating ingredients such as a-hydroxy acids (AHAs) and 3-hydroxy acids (BHAs). Exfoliation may also result from the use of facial masks, eg peel-off masks which dry after application and are then pulled off the skin, taking the dead skin cells with them. Other facial masks may have a granular texture that helps smooth the skin when the mask is massaged on and/or rinsed off. Skincare compositions of the type known as toners, which work by removing dirt and cells using a cotton ball or pad, may also exfoliate the skin to a certain extent.
Granular "scrub" ingredients that may be included in exfoliating compositions include natural granules such as sea salt, sugar, pumice, ground oatmeal, cornmeal, jojoba beads, powdered apricot and peach seeds and powdered walnut kernels. These granules are usually irregularly shaped and larger than synthetic granules. Synthetic scrub granules are usually small, spherical polyethylene beads.
Non-granular exfoliating ingredients include AHAs, eg glycolic acid, BHAs, eg salicylic acid, retinoic acid, papaya enzyme and honey. Detergents themselves can help remove the dead surface cells.
Both granular and non-granular exfoliating compositions have disadvantages, and consumers often cause skin damage by improper or too frequent use, especially consumers with sensitive skin or skin problems such as acne or rosacea.
Scrub ingredients, particularly the larger, irregularly shaped natural granules, may create tiny nicks or tears in facial skin, leaving it raw and scratched, or may become embedded in the skin. The use of harsh, abrasive exfoliators can damage existing spots and spread infection.
Over-exfoliating, particularly with compositions containing harsh surfactants, can remove too much of the skin's protective layer. The protective layer of the skin renders the skin waterproof and protects it from bacteria. Over-exfoliating can therefore lead to impaired protection against invading bacteria and even contribute to infection as dry skin provides micro-environments for skin bacteria.
AHAs and BHAs may have a short-term drying effect on the skin and this dehydrating effect can make oily skin look shiny. AHAs are known skin irritants and many consumers experience adverse effects ranging from mild irritation and stinging to blistering and burns. Also, there are concerns over the safety of AHAs and BHAs, and some studies have suggested that compositions containing AHAs may actually cause the skin to age more rapidly.
Facial cleansers and toners may remove some dead cells but may not provide the exfoliation required for dull, dehydrated skin, and do not leave the same skin-smoothness that a consumer would expect from a conventional exfoliating composition. Moreover, alcohol-based toners may remove protective skin lipids, thus contributing to duller skin in the longer term.
There thus exists a need for skincare compositions which leave the skin feeling as smooth as it does after conventional exfoliation, but which may be safer, less irritating or less drying, and which may reduce or eliminate the risk of scratching or tearing of the skin.
There have now been devised improved skincare compositions that address this need and which overcome or substantially mitigate the abovementioned and/or other disadvantages associated with the prior art.
Thus, according to the invention there is provided a skincare composition corn prising a) from 30% to 75% by weight of oil phase; b) from I % to 20% by weight of surfactant; c) from 0.01 to 20% by weight of an elastomer; and d) from 2% to 40% by weight of aqueous phase.
The compositions according to the invention are advantageous primarily in that they have a cleansing and smoothing effect on the skin, comparable to that of a conventional exfoliating composition. However, this effect may be achieved without the use of granular scrub materials or non- granular exfoliating ingredients such as AHAs and BHAs. The disadvantages of these conventional exfoliating ingredients, eg the risk of skin damage, irritation and adverse reactions, may therefore be reduced or substantially eliminated.
The composition will generally comprise a major proportion of oil phase. By "oil phase" is meant those ingredients (apart from the surfactant and elastomer, to the extent that those ingredients reside in the oil phase) that together constitute a hydrophobic phase that is physically distinct from the aqueous phase. Oil phase ingredients may include, for example, PPG-1 5 stearyl ether, ethylhexyl stearate, cetyl dimethicone, octyldodecanol, PPG-20 methyl glucose ether, isopropyl myristate isopropyl palmitate, isopropyl laurate isodecyl laurate, isodecyl neopentanoate, isohexadecane, pentaerythrityl tetraisostearate, caprylic/capric triglyceride, trihexanoin, canola oil, sunflower oil (Helianthus annuus), olive oil (Olea europea), cottonseed oil (Gossypium herbaceum), jojoba oil (Simmondsja chinensis), shea butter (Butyrospermum park/i), cocoa butter (Theobroma cacao), cupuacu butter (Theobroma grandiflorum), avocado oil (Persea grat/ssima), liquid paraffin, dimethicone, phenyl trimethicone, cyclopentasiloxane, dimethiconol or petrolatum. Other examples are waxes, eg tribehenin, which may also aid the stability of the composition.
The concentration of oil phase will typically be in excess of 30% by weight, more commonly in excess of 40% by weight, and preferably in excess of 45% by weight. The concentration of oil phase is preferably less than 75% by weight, more preferably less than 60%. The concentration of oil phase may therefore fall in the range 30% to 75% by weight, more preferably 40% to 60% by weight and most preferably 45% to 60% by weight.
Preferred oil phase ingredients are triglycerides, esters and/or silicones.
Particularly preferred oil phase ingredients are phenyl trimethicone and/or triglycerides such as triethylhexanoin and caprylic/capric triglyceride. The most preferred oil phase ingredient is caprylic/capric triglyceride.
The concentration of surfactant is preferably at least 5% by weight, more preferably at least 8% by weight. The concentration of surfactant is preferably less than 16% by weight, and most preferably less than 13% by weight. The concentration of surfactant may therefore fall in the range 5% to 20% by weight, more preferably 5% to 16% by weight and most preferably 8% to 13% by weight.
Examples of surfactants that may be present in the composition according to the invention include anionic surfactants, eg sodium lauryl sulphate, sodium laureth sulphate, sodium stearoyl lactylate, ammonium laureth sulphate, disodium laureth sulfosuccjnate and sodium Cl 2-15 pareth sulphate; amphoteric/zwifterionic surfactants, eg cocamidopropyl betaine, sodium cocoamphoacetate and cocamidopropyl hydroxysultaine; nonionic surfactants, eg laureth-3, oleth-5, cocamide DEA, cocamide MEA, PEG-5 cocamide, polysorbate 20, PEG-40 hydrogenated castor oil, Cl 2-Cl 3 pareth-3; and cationic surfactants, eg cetrimonium chloride, behentrimonium chloride and benzalkonium chloride.
Preferred surfactants are surfactants with HLB values in the range 12 to 18.
Surfactants having an HLB value outside of this range can be used in combination with other surfactants to achieve an effective weighted average HLB for the combination, which fafls in the range 12 to 18. More preferably, surfactants have HLB values above 14, and are either anionic or non-ionic.
Particularly preferred surfactants are non-ionic surfactants. Such surfactants may have a milder effect on the skin than anionic surfactants at high concentrations. Anionic surfactants may be drying and irritating at high concentrations, and may cause stinging. The most preferred surfactants are octyldodeceth-25 or polysorbate 20.
By "elastome," in this context is meant ingredients of the type referred to by that name by those skilled in the field of cosmetics and toiletries. Particular examples include silicone elastomers, eg of the dimethicone cross-polymer type, as described in the International Cosmetics Ingredient Dictionary and Handbook (9th edition), which is a polymer of dimethylpolysiloxane cross- linked with a 3- to 20-carbon alkyl group. Dimethylpolysiloxane polymers cross-linked with alkyl groups that have 1and 2-carbons are also available, and these may be equally suitable.
Suitable elastomers are commercially available as blends under the trade names Dow Corning 9040 (comprising dimethicone crosspolymer and cyclomethicone) and 9042 (comprising dimethicone crosspolymer and dimethicone).
The concentration of elastomer preferably ranges from 0.5% to 10% by weight and more preferably from I % to 5% by weight. The most preferable concentration of elastomer is 2.5% by weight of the composition.
The elastomer is most preferably a particulate elastomer, particularly a dimethicone/vinyi dimethicone cross polymer, ie dimethylpolysiloxane cross polymerised with vinyl dimethyl polysiloxane. The elastomer is preferably dispersed in a volatile silicone, eg cyclopentasiloxane. A suitable elastomer is available under the trade name Dow Corning 9506 cosmetic powder. Similar materials are available as KM9729 from Shin-Etsu, Gransil RPS-NA from Grant Industries and SFE839 from GE Silicones.
The elastomer preferably exhibits shear-thinning behaviour when rubbed onto the skin, enhancing spreadability and skin-feel upon application. The inclusion of an elastomer is essential to the smooth after-feel desired. The elastomer may also thicken and/or stabilise the composition, and it may be desirable to use more than one elastomer in order to obtain the optimum stability, viscosity and skin-feel.
Conventional compositions with a high proportion of oil are, in most circumstances, difficult to rinse off the skin and this potential disadvantage would be expected to be exacerbated by the inclusion of a non-aqueous elastomer, which would not normally rinse off with water. However, the composition according to the invention has a superior rinseoff capability that can be attributed to the high concentration of surfactant. The composition is massaged into the skin and then rinsed off with water. Upon contact with water, the high concentration of surfactant causes the composition spontaneously to form an emulsion with the water, which can be rinsed off the skin easily.
The "aqueous phase" consists largely of water plus whatever water-soluble and/or water-miscible ingredients (apart from the surfactant and elastomer, to the extent that those ingredients reside in the aqueous phase) are dissolved or dispersed in it, eg glycerine.
The concentration of the aqueous phase preferably ranges from 10% to 30% by weight.
Compositions according to the invention have a low concentration of aqueous phase compared to the concentration of oil phase; preferably a ratio between 1:4 and 1:2 of aqueous phase to oil phase, and more preferably between 1:3 and 1:2 aqueous phase to oil phase.
The composition may additionally include a fine particulate ingredient. Such an ingredient may be a so-called "pearl" or pearlescent agent, eg mica powder coated with titanium dioxide colour, to modify the appearance of the composition by providing a colour and a shimmering and/or pearlescent effect.
Such powders may have particle sizes in the range 5pm to 200pm. In addition to modifying the appearance of the composition it has been found that such ingredients may increase the viscosity and may enhance spreadability and smooth skin-feel.
The concentration of particulate material, eg mica plus colour, preferably ranges from 0.05% to 10% by weight, more preferably from 0.1 % to 2%, and most preferably from 0.1% to 1% by weight of the composition.
The inclusion of a powder such as a "pearl" has also been shown to stabilise the composition, ie to reduce or prevent phase separation over a period of time. Consequently, other particulates may be added to help improve stability, eg bentone, microcrystalline waxes or clays such as disteardimonium hectonite. It should be noted that it is the particulate nature of the elastomer that is believed to confer improved stability.
As described above, the compositions according to the invention, which do not contain any conventional exfoliating ingredients, still have the perceived skin- smoothing effects of a conventional exfoliator product. The compositions according to the invention are thus preferentially free, or substantially free, of granular and non-granular exfoliating ingredients. By "substantially free" is meant that the level of such ingredients is lower than that required to achieve any significant exfoliating effect, eg less than I %, more preferably less than 0.5% or 0.1% by weight. Nonetheless, certain embodiments of the invention may include such ingredients, though the level at which they are present may be lower than is customary.
Conventional non-granular exfoliating ingredients include AHAs and BHAs.
Examples of AHAs include glycolic acid, lactic acid, methyllactic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyheptanojc acid, 2-hydroxyoctanojc acid, 2-hydroxynonanoic acid, 2-hydroxydecanoic acid, 2-hydroxyundecanoic acid, alpha hydroxylauric acid, alpha hydroxymyristic acid, alpha hydroxypalmjtjc acid, alpha hydroxysteanc acid and alpha hydroxyarachjdonjc acid; aralkyl and aryl alpha hydroxyacids, for example, mandelic acid, benzilic acid, phenyllactic acid and polyhydroxy alpha hydroxyacici; polycarboxylic alpha hydroxyacids, for example, glyceric acid, erythronic acid, threonic acid, ribonic acid, arabinoic acid, xylonic acid, lyxonic acid, allonic acid, altronic acid, gluconic acid, mannoic acid, gulonic acid, idonic acid galactonic acid, talonic acid, tartronic acid, malic acid, tartaric acid, citric acid; and lactone forms, for example, gluconolactone, galactonolactone, glucuronolactone, galacturonolactone, gulonolactorie, ribonolactone saccharic acid lactone, pantoyllactone, glucoheptonolactone, mannonolactone and galactoheptonolactone Examples of BHAs include salicylic acid, 3-hydroxypropanoic acid, 3-hydroxybutanoic acid, acid, 3-hyd roxy-3-methylpenta noic acid, 3-hyd roxy-2-aminopentanojc acid, tropic acid, 3-hyd roxy-3-methylglutaric acid, and 3-hyd roxypentanoic acid.
Conventional granular exfoliating ingredients include natural granules such as sea salt, sugar pumice, ground oatmeal, cornmeal, jojoba beads, and powdered apricot seeds, peach seeds and walnut kernels; and synthetic granules such as polyethylene beads.
The composition according to the invention may additionally comprise other ingredients which will be well known to those skilled in the art. These include,
for example:
a) Humectants such as glycerin, propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol, polyethylene glycol, sorbitol, urea, xylitol, lactitol, lactic acid and salts, fructose, glucose, mannose, xylose, honey, and pyrrolidone carboxylic acid and salts thereof.
b) Natural extracts, vitamins or other actives, for example Vitamin C (ascorbic acid) its salts, esters, glucosides and glucosamines, Vitamin E (tocopherol) and its esters, herbal extracts such as Panax ginseng, Morus a/ba, Origanum vulgare and Rosmarinus officinalis.
c) Preservatives - ingredients which prevent or retard microbial growth and thus protect the composition from spoilage. Examples of preservatives include DMDM hydantoin, propylparaben, methylparaben, phenoxyethanol, sodium benzoate, bronopol, sodium dehydroacetate, polyhexamethylenebiguanide hydrochloride, isothiazolone and diazolidinylurea.
d) Perfumes and colourings.
According to a further aspect of the invention, there is provided a method for cleansing the skin, which method comprises the application to the skin of a skincare composition as described above.
The invention will now be described in greater detail, by way of illustration only, with reference to the following Examples.
ExamDle I INCI Name % w/w Caprylic/capric triglyceride 47.25 Cyclopentasiloxane 17.5 Aqua 12.0225 Polysorbate 20 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.5 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0. 41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 2
INCI Name % w/w Caprylic/capric triglyceride 44.25 Cyclopentasiloxane 17. 5 Aqua 15.0225 Polysorbate 20 11.8 Glycerin 7.90 Dimethicone crosspolymer 2.5 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 3
INCI Name % w/w Caprylic/capric triglyceride 39.25 Cyclopentasiloxane 17. 5 Aqua 20.0225 Polysorbate 20 11.8 Glycerin 7.9 Dimethicone crosspolymer 2.5 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 4
INCI Name %w/w Caprylic/capric triglyceride 50.95 Cyclopentasiloxane 17.5 Aqua 12.0225 Polysorbate 20 8.0 Glycerin 8.0 Dimethicone crosspolymer 2.5 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Mthod of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 5
INCI Name %w/w Caprylic/caprjc triglyceride 48.95 Cyclopentasjloxane 17.5 Aqua 10.0225 Polysorbate 20 12.0 Glycerin 8.0 Dimethicone crosspolymer 2. 5 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
ExamDle6 INCI Name % w/w Caprylic/capric triglyceride 50.95 Cyclopentasiloxane 17.5 Aqua 8.0225 Polysorbate 20 12.0 Glycerin 8.0 Dimethicone crosspolymer 2.5 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0. 41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 7
INCI Name %w/w Caprylic/capric triglyceride 47.25 Cyclopentasiloxane 17.5 Aqua 12.0225 Polysorbate 20 12.0 Glycerin 8.0 Dimethicone crosspolymer 2. 5 DMDM hydantoin 0.0275 iyithod of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 8
INCI Name %w/w Caprylic/capric triglyceride 47.25 Cyclopentasiloxane 17. 50 Aqua 12.0225 C12-13 pareth-3 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.50 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, C12-13 pareth-3 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
ExamDle 9 INCI Name % w/w Caprylic/capric triglyceride 27.25 Phenyl trimethicone 20.00 Cyclopentasijoxane 17.50 Aqua 12.0225 Polysorbate 20 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.50 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and phenyl trimethicone and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
ExamDle 10 INCI Name % w/w Caprylic/capric triglyceride 47.25 Aqua 12. 0225 Cyclopentasiloxane 17.50 Polysorbate 20 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.50 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0. 41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 11
INCI Name %w/w Caprylic/capric triglyceride 43.25 Cyclopentasiloxane 20. 58 Aqua 12.0225 Polysorbate 20 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.50 Disteardimonium hectorite 0.72 Mica 0.59 Propylene carbonate 0.20 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin, disteardimonjum hectorite, propylene carbonate and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 12
INCI Name % wiw Caprylic/capric triglyceride 47.05 Cyclopentasiloxane 17. 50 Aqua 12.0225 Polysorbate 20 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.50 Mica 0.59 Sodium stearoyl lactylate 0.20 DMDM hydantoin 0.0275 Cl 77891 0.41 ithod of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20, sodium stearoyl lactylate and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 13
INCI Name % w/w Caprylic/capric triglyceride 47.25 Cyclopentasiloxane 17. 50 Aqua 12.0225 Polysorbate 20 11.82 Glycerin 7.88 Dimethicone crosspolymer 2.50 Mica 1.77 DMDM hydantoin 0.0275 Cl 77891 1.23 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer (cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Example 14
INCI Name % w/w Caprylic/capric triglyceride 47.25 Cyclopentasiloxane 17. 50 Aqua 12.0225 Polysorbate 20 11.82 Glycerin 7.88 Dimethjcone crosspolymer 2.50 Tribehenjn 2.00 Mica 0.59 DMDM hydantoin 0.0275 Cl 77891 0.41 Method of manufacture Weigh out aqua (water) and mix with mica, Cl 77891, Polysorbate 20 and glycerine. Heat to 80 C. Weigh out caprylic/capric triglyeride and tribehenin, and heat to 80 C. With both phases at 80 C, slowly stir the oil into the water phase using a propeller stirrer. Cool to below 30 C with constant stirring. Once cool add DMDM hydantoin and the silicone elastomer
(cyclopentasiloxane and dimethicone crosspolymer) with stirring, then homogenise for 2 minutes until fully smooth.
Claims (30)
- Claims 1. A skincare composition comprising: a) from 30% to 75% by weightof oil phase; b) from I % to 20% by weight of surfactant; c) from 0.01 to 20% by weight of an elastomer; and d) from 2% to 40% by weight of aqueous phase.
- 2. A composition as claimed in Claim 1, wherein the concentration of the oil phase is in excess of 40% by weight, and preferably in excess of 45% by weight.
- 3. A composition as claimed in Claim 1, wherein the concentration of the oil phase is less than 60% by weight.
- 4. A composition as claimed in Claim 1, wherein the concentration of the oil phase is in the range 40% to 60%, and more preferably 45% to 60% by weight.
- 5. A composition as claimed in Claim 1, wherein the oil phase ingredients are selected from the group consisting of triglycerides, esters, silicones, and mixtures thereof.
- 6. A composition as claimed in Claim 5, wherein the oil phase comprises phenyl trimethicone and/or triglycerides.
- 7. A composition as claimed in Claim 6, where in the oil phase comprises caprylic/capric triglyceride.
- 8. A composition as claimed in Claim 1, wherein the concentration of surfactant is at least 5% by weight.
- 9. A composition as claimed in Claim 8, wherein the concentration of surfactant is at least 8% by weight.
- 10. A composition as claimed in Claim 1, wherein the concentration of surfactant is less than 16% by weight.
- 11. A composition as claimed in Claim 10, wherein the concentration of surfactant is less than 13% by weight.
- 12. A composition as claimed in Claim 1, wherein the concentration of surfactant is in the range of 5% to 20% by weight.
- 13. A composition as claimed in Claim 12, wherein the concentration of surfactar,t is in the range of 8% to 13% by weight.
- 14. A composition as claimed in Claim 1, wherein the surfactant or surfactants used have HLB values in the range 12-18, or the combination of surfactants used achieves an average HLB, which falls in the range 12 to 18.
- 15. A composition as claimed in Claim 14, wherein the surfactant or surfactants have HLB values above 14.
- 16. A composition as claimed in Claim 14 or 15, wherein the surfactant or surfactants are anionic or non-ionic.
- 17. A composition as claimed in Claim 16, which comprises octyldodeceth25 or polysorbate 20.
- 18. A composition as claimed in Claim 1, wherein the concentration of elastomer is from 0.5% to 10% by weight.
- 19. A composition as claimed in Claim 18, wherein the concentration of elastomer is from 1% to 5% by weight.
- 20. A composition as claimed in Claim 19, wherein the concentration of elastomer is 2.5%.
- 21. A composition as claimed in Claim 1, wherein the elastomer is a dimethicone crosspolymer.
- 22. A composition as claimed in Claim 21, wherein the dimethicone crosspolymer is a dimethicone/vinyl dimethicone crosspolymer.
- 23. A composition as claimed in Claim 1, wherein the concentration of aqueous phase is 10% to 30% by weight.
- 24. A composition as claimed in Claim 1, wherein the aqueous phase and the oil phase are present at a weight ratio of between 1:4 and 1:2.
- 25. A composition as claimed in any preceding claim, which further comprises a fine particulate ingredient.
- 26. A composition as claimed in Claim 25, wherein the fine particulate ingredient is a pearlescent agent, wax or clay.
- 27. A composition as claimed in Claim 25, wherein the concentration of particulate ingredient is between 0.05% and 10% by weight.
- 28. A composition as claimed in Claim 27, wherein the concentration of particulate ingredient is between 0.1 to 1% by weight.
- 29. A composition as claimed in any preceding claim, which comprises one or more excipients selected from the group consisting of exfoliating ingredients, humectants, natural extracts, preservatives, chelating agents, perfumes and colourings.
- 30. A method for cleansing the skin, which method comprises the application to the skin of a skincare composition as claimed in any preceding claim.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0422918.3A GB0422918D0 (en) | 2004-10-15 | 2004-10-15 | Skincare composition |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0520896D0 GB0520896D0 (en) | 2005-11-23 |
GB2420076A true GB2420076A (en) | 2006-05-17 |
GB2420076B GB2420076B (en) | 2010-05-19 |
Family
ID=33462771
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0422918.3A Ceased GB0422918D0 (en) | 2004-10-15 | 2004-10-15 | Skincare composition |
GB0520896A Expired - Fee Related GB2420076B (en) | 2004-10-15 | 2005-10-14 | Skincare composition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0422918.3A Ceased GB0422918D0 (en) | 2004-10-15 | 2004-10-15 | Skincare composition |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB0422918D0 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2042216A1 (en) * | 2007-09-28 | 2009-04-01 | ACO Hud Nordic AB | Body and hair cleansing formulations |
US11253463B2 (en) | 2018-01-08 | 2022-02-22 | Conopco, Inc. | Cosmetic compositions comprising silicone elastomer and emollient |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0917870A1 (en) * | 1997-11-21 | 1999-05-26 | Unilever Plc | Crosslinked elastomeric silicones in aqueous emulsion cosmetic compositions |
EP1097695A1 (en) * | 1999-11-08 | 2001-05-09 | L'oreal | Composition containing an aqueous suspension of particles of an organopolysiloxane elastomer and cosmetical uses thereof |
US6667044B1 (en) * | 1996-10-04 | 2003-12-23 | Beiersdorf Ag | Cosmetic or dermatological gels based on microemulsions |
WO2004100906A2 (en) * | 2003-05-08 | 2004-11-25 | The Procter & Gamble Company | Personal care compositions containing a silicone elastomer and a dispersed oil phase |
WO2004100921A1 (en) * | 2003-05-08 | 2004-11-25 | The Procter & Gamble Company | Method for depositing shiny particles on keratinous surfaces from rinse-off compositions |
WO2004103326A1 (en) * | 2003-05-16 | 2004-12-02 | Dow Corning Corporation | Personal care applications of emulsions containing elastomeric silanes and siloxanes with nitrogen atoms |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599533A (en) * | 1994-12-15 | 1997-02-04 | Estee Lauder, Inc. | Stable water-in-oil emulsion system |
ZA971943B (en) * | 1996-06-28 | 1998-09-07 | Unilever Plc | Vitamin C delivery system |
US6051216A (en) * | 1997-08-01 | 2000-04-18 | Colgate-Palmolive Company | Cosmetic composition containing siloxane based polyamides as thickening agents |
US6403069B1 (en) * | 2000-10-20 | 2002-06-11 | Colgate-Palmolive Company | High oil clear emulsion with elastomer |
BR0209782A (en) * | 2001-05-29 | 2004-06-01 | Procter & Gamble | Skin Care Kit |
-
2004
- 2004-10-15 GB GBGB0422918.3A patent/GB0422918D0/en not_active Ceased
-
2005
- 2005-10-14 GB GB0520896A patent/GB2420076B/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6667044B1 (en) * | 1996-10-04 | 2003-12-23 | Beiersdorf Ag | Cosmetic or dermatological gels based on microemulsions |
EP0917870A1 (en) * | 1997-11-21 | 1999-05-26 | Unilever Plc | Crosslinked elastomeric silicones in aqueous emulsion cosmetic compositions |
EP1097695A1 (en) * | 1999-11-08 | 2001-05-09 | L'oreal | Composition containing an aqueous suspension of particles of an organopolysiloxane elastomer and cosmetical uses thereof |
WO2004100906A2 (en) * | 2003-05-08 | 2004-11-25 | The Procter & Gamble Company | Personal care compositions containing a silicone elastomer and a dispersed oil phase |
WO2004100921A1 (en) * | 2003-05-08 | 2004-11-25 | The Procter & Gamble Company | Method for depositing shiny particles on keratinous surfaces from rinse-off compositions |
WO2004103326A1 (en) * | 2003-05-16 | 2004-12-02 | Dow Corning Corporation | Personal care applications of emulsions containing elastomeric silanes and siloxanes with nitrogen atoms |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2042216A1 (en) * | 2007-09-28 | 2009-04-01 | ACO Hud Nordic AB | Body and hair cleansing formulations |
US11253463B2 (en) | 2018-01-08 | 2022-02-22 | Conopco, Inc. | Cosmetic compositions comprising silicone elastomer and emollient |
Also Published As
Publication number | Publication date |
---|---|
GB0422918D0 (en) | 2004-11-17 |
GB2420076B (en) | 2010-05-19 |
GB0520896D0 (en) | 2005-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2345901T3 (en) | COMPOSITIONS TO CLEAN THE SKIN THAT CAN BE CLEARED OR REMOVED. | |
US7001603B2 (en) | Gelled two phase cosmetic compositions | |
US11166905B2 (en) | Skin cleansing compositions comprising color stable abrasive particles | |
KR20060008973A (en) | Wet skin treatment compositions comprising gel-networks | |
WO2003037282A1 (en) | Method of using personal care compositions containing a high density, water disintegratable, polymeric foam | |
CN102946850A (en) | Skin improving dermo-cosmetics | |
US11419801B2 (en) | Personal care composition | |
KR20220068226A (en) | Cosmetic or dermatological composition for removing and/or cleansing makeup comprising succinic acid for preventing, reducing or eliminating skin imperfections, treating skin disorders and preventing, treating and combating hyperseborrheic conditions of the scalp | |
US9029422B2 (en) | Use of ((ethoxy)hydroxyphenyl)alkyl ketone or ethoxyhydroxyalkylphenol compounds for treating greasy skin | |
DE10259016A1 (en) | Moist sponge for cleansing or application of cosmetics or other agents has specified maximum water absorption capacity and is especially of natural or synthetic rubber or polyurethane | |
GB2420076A (en) | Skincare composition | |
KR20060009904A (en) | Personal care compositions containing a silicone elastomer and a dispersed oil phase | |
DE10327707A1 (en) | Multipurpose cosmetics-containing rubber foam sponge for non-therapeutic cosmetic or dermatological treatment is especially of natural or synthetic rubber or polyurethane | |
KR100570498B1 (en) | The cosmetic product of skin exfoliation containing film-forming fabrics and powders | |
JP2004168785A (en) | Cosmetic | |
JP2007302611A (en) | Facial cleanser | |
JP2007297351A5 (en) | ||
KR20170082987A (en) | Water-in-Oil Cosmetic Composition with Shape-Memory Ability | |
JP2009256254A5 (en) | ||
JP2009256253A5 (en) | ||
CN115427006A (en) | Dispersant or dispersion medium composition containing 2, 3-butanediol and cosmetic composition containing same | |
CN101090752A (en) | Rinse-off or wipe-off skin cleansing compositions | |
JP2009234933A (en) | Skin external preparation | |
JP2007119401A (en) | Skin care preparation for horny plug removal | |
JP7502860B2 (en) | Cleaning composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20161014 |